Overview AZD2115 Single Ascending Dose Study Status: Completed Trial end date: 2011-08-01 Target enrollment: Participant gender: Summary AZD2115 Single Ascending Dose Study Phase: Phase 1 Details Lead Sponsor: AstraZeneca